{
    "organizations": [],
    "uuid": "e8481dd2ba2a3c72d140abd43ff0b0387e65fee1",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-beigene-initiates-phase-3-trial-of/brief-beigene-initiates-phase-3-trial-of-pamiparib-as-maintenance-therapy-in-chinese-patients-with-ovarian-cancer-idUSASC0A2QU",
    "ord_in_thread": 0,
    "title": "BRIEF-Beigene Initiates Phase 3 Trial Of Pamiparib As Maintenance Therapy In Chinese Patients With Ovarian Cancer",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 17 (Reuters) - Beigene Ltd:\n* BEIGENE INITIATES PHASE 3 TRIAL OF PAMIPARIB AS MAINTENANCE THERAPY IN CHINESE PATIENTS WITH OVARIAN CANCER Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-05-17T19:13:00.000+03:00",
    "crawled": "2018-05-18T19:53:30.003+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "beigene",
        "ltd",
        "beigene",
        "initiate",
        "phase",
        "trial",
        "pamiparib",
        "maintenance",
        "therapy",
        "chinese",
        "patient",
        "ovarian",
        "cancer",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}